Vivos (RDGL) EBIT Growth (1y) (2011 - 2025)
Powered by 
Analysis
Vivos (RDGL) EBIT Growth (1y) (2011 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -17.50% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 30.74% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 22.08% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 49.06% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 43.83% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 24.81% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -95.55% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 49.72% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 16.18% |
| 10 | Vivos | 24.71 Mn | 24.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -65.57% |
| Sep 30, 2025 | 37.02% |
| Jun 30, 2025 | -29.19% |
| Mar 31, 2025 | -49.63% |
| Dec 31, 2024 | 29.80% |
| Sep 30, 2024 | -22.62% |
| Jun 30, 2024 | 42.88% |
| Mar 31, 2024 | -132.42% |
| Dec 31, 2023 | -33.61% |
| Sep 30, 2023 | -148.18% |
| Jun 30, 2023 | -16.11% |
| Mar 31, 2023 | 66.78% |
| Dec 31, 2022 | -223.04% |
| Sep 30, 2022 | -42.39% |
| Jun 30, 2022 | 57.52% |
| Mar 31, 2022 | -217.96% |
| Dec 31, 2021 | 26.02% |
| Sep 30, 2021 | -51.50% |
| Jun 30, 2021 | -1,343.08% |
| Mar 31, 2021 | -95.30% |